Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine

被引：39
|
作者：
Christie, S
Göbel, H
Mateos, V
Allen, C
Vrijens, F
Shivaprakash, M
机构：
[1] Merck & Co Inc, Dept WS3C 90, Whitehouse Stn, NJ 08889 USA
[2] Ottawa Headache Ctr, Ottawa, ON, Canada
[3] Univ Kiel, Kiel Pain Clin, Kiel, Germany
[4] Ctr Hosp Asturias, Dept Neurol, Oviedo, Spain
[5] Merck Sharp & Dohme Europe, Brussels, Belgium
来源：
EUROPEAN NEUROLOGY | 2003年 / 49卷 / 01期
关键词：
rizatriptan; ergotamine; efficacy; preference; migraine;
D O I：
10.1159/000067018
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：20 / 29
页数：10
相关论文
共 50 条
  • [41] Improved migraine treatment outcomes with rizatriptan 10 mg compared to nontriptant treatment (I-Max migraine disability assessment program - Spain
    Torrecilla, M
    Castellanos, A
    Torres, M
    Caloto, T
    Nocea, G
    William, G
    CEPHALALGIA, 2003, 23 (07) : 715 - 715
  • [42] Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg
    Allain, H
    Bentué-Ferrer, D
    Le Breton, S
    Polard, E
    Gandon, JM
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2003, 18 (05) : 369 - 374
  • [43] FLUNARIZINE IN MIGRAINE PROPHYLAXIS - EFFICACY AND TOLERABILITY OF 5 MG AND 10 MG DOSE LEVELS
    CENTONZE, V
    MAGRONE, D
    VINO, M
    CAPORALETTI, P
    ATTOLINI, E
    CAMPANALE, G
    ALBANO, O
    CEPHALALGIA, 1990, 10 (01) : 17 - 24
  • [44] Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot®) in the acute treatment of migraine:: A multicentre, randomised, double-blind, placebo-controlled comparison
    Diener, HC
    Jansen, JP
    Reches, A
    Pascual, J
    Pitei, D
    Steiner, TJ
    EUROPEAN NEUROLOGY, 2002, 47 (02) : 99 - 107
  • [45] Comparison of efficacy and safety of atorvastatin (10 mg) with simvastatin (10 mg) at six weeks
    Insull, W
    Kafonek, S
    Goldner, D
    Zieve, F
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (05): : 554 - 559
  • [46] Comparison of the efficacy of propranolol versus amitriptyline as monotherapy for prophylaxis of migraine
    Patel, Krinaben M.
    Popatbhai, Kachhadia M.
    Xavier, Roshni
    Aramin, Mohammed A. S.
    Faris, Khalid J. F.
    Mateen, Mohammed A.
    Prajwal, Priyadarshi
    Marsool, Mohammed D. M.
    Sheikh, Hafsa
    Mohamed, Esra H. A. G.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (02) : 699 - 703
  • [47] Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study
    Salonen, R
    Ashford, EA
    Hassani, H
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, : 16 - 24
  • [48] Efficacy and safety of 400 and 800 mg etodolac versus 1000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, clinical trial
    Ozturk, V.
    Ertas, M.
    Baykan, B.
    Sirin, H.
    Ozge, A.
    CEPHALALGIA, 2011, 31 (01) : 25 - 26
  • [49] META-ANALYSIS ON COMPARISON OF EFFICACY AND TOLERABILITY OF ROSUVASTATIN 5 MG/EZETIMIBE 10 MG VERSUS ROSUVASTATIN 20 MG MONOTHERAPY
    Lee, S. -H.
    ATHEROSCLEROSIS, 2022, 355 : E299 - E300
  • [50] Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine
    Fox, Anthony W.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (05) : 513 - 516
12345